Cell and gene therapy developers continue to face mounting pressure to improve manufacturing efficiency while maintainin...
US-based Eli Lilly and Company has announced agreements to acquire three companies, Curevo Inc., LimmaTech Biologic...
The University of Melbourne and radiopharmaceutical manufacturer Cyclotek have opened the Laboratory for Advanced R...
China-based Innovent Biologics and American firm Pfizer Inc. have entered into a strategic global licensing and collabor...
Japan-based Meiji Seika Pharma Co. has committed to invest in the Global Health Security Fund (GHSF), which is sponsored...
As cell and gene therapies transition from clinical development to commercial reality, the industry's attention is incre...
Artificial intelligence (AI) has reshaped drug discovery, diagnostics, and genomics. The nutraceutical sector has been s...
South Korea-based Hanmi Pharmaceutical has signed a supply agreement with global healthcare company Organon to export th...
Lotus Pharmaceutical, a global pharmaceutical company headquartered in Taiwan, has entered into an agreement with OM Pha...
On May 15, 2026, China’s National Medical Products Administration (“NMPA”) issued the Implementat...
OncoSil Medical has received approval from the Australian Therapeutic Goods Administration (TGA) for the OncoSil™ ...
South Korea-based Hyundai Bioscience has announced that it can supply clinical trial doses of its broad-spectrum antivir...
Nutraceutical ingredients innovator SUANNUTRA USA has inked a distribution agreement with Spanish biotech company Fitopl...
South Korea-based Samsung Bioepis has announced the launch of Ustekinumab BS 45 mg Syringe for S.C. Injection「&nb...
Jordan headquartered MS Pharma has announced that Olayan Financing Company (OFC) has made a minority equity investment i...
South Korea-based LOTTE Biologics has announced an expansion of its collaboration with UK-based Ottimo Pharma, an innova...
Most pharma digitalisation projects never leave the pilot stage. AUTOMA+ 2026 is built for the ones that do. Fragmented ...
Shanghai Fosun Pharmaceutical (Group) and South Korea-based AriBio Co., a biopharmaceutical company focused on neurodege...
Reporting on ground from API China 2026, BioSpectrum Asia observed growing industry attention around the Middle East and...
Reporting on ground from API China 2026, BioSpectrum Asia observed strong international interest aro...
Reporting on ground from API China 2026, BioSpectrum Asia observed a strong strategic focus on the f...
China’s pharmaceutical industry is rapidly advancing towards intelligent manufacturing ecosystems, with smart phar...
Duke-NUS Medical School has broadened access to medicine for students across various academic backgrounds, including Chi...
The opening session of the 2026 Pharmaceutical Innovation And Compliance Development Forum,...
API China 2026 was officially inaugurated today alongside co located industry exhibitions including PharmChina 2026, NHN...
